From DCAT Value Chain Insights (VCI)
Gilead Sciences has appointed Kennet Brysting as general manager (GM) of Gilead Sciences Canada, succeeding Ed Gudaitis, who left the company in October 2016 for another opportunity. Mr. Brysting’s appointment to GM was effective on January 9, 2017.
The former GM of Gilead Nordics (Sweden, Norway, Denmark, Finland, and Iceland), Mr. Brysting also joins Gilead's North America commercial senior leadership team. Mr. Brysting has nearly 20 years of industry experience, including prior pharmaceutical industry GM experience, and more than four years as the GM for Gilead Nordics.
Source: Gilead Sciences
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription